“The human APO-1 (APT) antigen maps to 10q23, a region that is syntenic with mouse chromosome 19”. Genomics14 (1): 179–80. (September 1992). doi:10.1016/S0888-7543(05)80302-7. PMID1385299.
“Early work on the function of CD95, an interview with Shige Nagata”. Cell Death and Differentiation11 Suppl 1 (Suppl 1): S23-7. (July 2004). doi:10.1038/sj.cdd.4401453. PMID15143352.
“Regulation of Fas alternative splicing by antagonistic effects of TIA-1 and PTB on exon definition”. Molecular Cell19 (4): 475–84. (August 2005). doi:10.1016/j.molcel.2005.06.015. PMID16109372.
“Cytoskeleton-mediated death receptor and ligand concentration in lipid rafts forms apoptosis-promoting clusters in cancer chemotherapy”. The Journal of Biological Chemistry280 (12): 11641–7. (March 2005). doi:10.1074/jbc.M411781200. PMID15659383.
“Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL”. The Journal of Biological Chemistry272 (41): 25417–20. (October 1997). doi:10.1074/jbc.272.41.25417. PMID9325248.
“Fas-associated death domain protein interleukin-1beta-converting enzyme 2 (FLICE2), an ICE/Ced-3 homologue, is proximally involved in CD95- and p55-mediated death signaling”. The Journal of Biological Chemistry272 (10): 6578–83. (March 1997). doi:10.1074/jbc.272.10.6578. PMID9045686.
“FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis”. Cell81 (4): 505–12. (May 1995). doi:10.1016/0092-8674(95)90071-3. PMID7538907.
“Regulation of Fas-associated death domain interactions by the death effector domain identified by a modified reverse two-hybrid screen”. The Journal of Biological Chemistry277 (37): 34343–8. (September 2002). doi:10.1074/jbc.M204169200. PMID12107169.
“Apoptosis-linked gene 2 binds to the death domain of Fas and dissociates from Fas during Fas-mediated apoptosis in Jurkat cells”. Biochemical and Biophysical Research Communications288 (2): 420–6. (October 2001). doi:10.1006/bbrc.2001.5769. PMID11606059.
“Interaction of Daxx, a Fas binding protein, with sentrin and Ubc9”. Biochemical and Biophysical Research Communications279 (1): 6–10. (December 2000). doi:10.1006/bbrc.2000.3882. PMID11112409.
“The human APO-1 (APT) antigen maps to 10q23, a region that is syntenic with mouse chromosome 19”. Genomics14 (1): 179–80. (September 1992). doi:10.1016/S0888-7543(05)80302-7. PMID1385299.
“Early work on the function of CD95, an interview with Shige Nagata”. Cell Death and Differentiation11 Suppl 1 (Suppl 1): S23-7. (July 2004). doi:10.1038/sj.cdd.4401453. PMID15143352.
“Regulation of Fas alternative splicing by antagonistic effects of TIA-1 and PTB on exon definition”. Molecular Cell19 (4): 475–84. (August 2005). doi:10.1016/j.molcel.2005.06.015. PMID16109372.
“Cytoskeleton-mediated death receptor and ligand concentration in lipid rafts forms apoptosis-promoting clusters in cancer chemotherapy”. The Journal of Biological Chemistry280 (12): 11641–7. (March 2005). doi:10.1074/jbc.M411781200. PMID15659383.
“Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL”. The Journal of Biological Chemistry272 (41): 25417–20. (October 1997). doi:10.1074/jbc.272.41.25417. PMID9325248.
“Fas-associated death domain protein interleukin-1beta-converting enzyme 2 (FLICE2), an ICE/Ced-3 homologue, is proximally involved in CD95- and p55-mediated death signaling”. The Journal of Biological Chemistry272 (10): 6578–83. (March 1997). doi:10.1074/jbc.272.10.6578. PMID9045686.
“FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis”. Cell81 (4): 505–12. (May 1995). doi:10.1016/0092-8674(95)90071-3. PMID7538907.
“Regulation of Fas-associated death domain interactions by the death effector domain identified by a modified reverse two-hybrid screen”. The Journal of Biological Chemistry277 (37): 34343–8. (September 2002). doi:10.1074/jbc.M204169200. PMID12107169.
“Apoptosis-linked gene 2 binds to the death domain of Fas and dissociates from Fas during Fas-mediated apoptosis in Jurkat cells”. Biochemical and Biophysical Research Communications288 (2): 420–6. (October 2001). doi:10.1006/bbrc.2001.5769. PMID11606059.
“Protection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin”. Journal of Immunology157 (10): 4277–81. (November 1996). PMID8906799.
“Interaction of Daxx, a Fas binding protein, with sentrin and Ubc9”. Biochemical and Biophysical Research Communications279 (1): 6–10. (December 2000). doi:10.1006/bbrc.2000.3882. PMID11112409.